IRIDEX Total Liabilities 2012-2026 | IRIX
IRIDEX total liabilities from 2012 to 2026. Total liabilities can be defined as the total value of all possible claims against the corporation.
|
IRIDEX Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2025 | $24 |
| 2024 | $27 |
| 2023 | $25 |
| 2022 | $25 |
| 2021 | $25 |
| 2020 | $11 |
| 2019 | $12 |
| 2018 | $12 |
| 2017 | $11 |
| 2016 | $9 |
| 2015 | $8 |
| 2014 | $8 |
| 2013 | $8 |
| 2012 | $7 |
| 2011 | $10 |
|
IRIDEX Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2026-03-31 | $24 |
| 2025-12-31 | $24 |
| 2025-09-30 | $24 |
| 2025-06-30 | $26 |
| 2025-03-31 | $27 |
| 2024-12-31 | $27 |
| 2024-09-30 | $28 |
| 2024-06-30 | $27 |
| 2024-03-31 | $28 |
| 2023-12-31 | $25 |
| 2023-09-30 | $23 |
| 2023-06-30 | $23 |
| 2023-03-31 | $25 |
| 2022-12-31 | $25 |
| 2022-09-30 | $27 |
| 2022-06-30 | $26 |
| 2022-03-31 | $27 |
| 2021-12-31 | $25 |
| 2021-09-30 | $25 |
| 2021-06-30 | $24 |
| 2021-03-31 | $24 |
| 2020-12-31 | $11 |
| 2020-09-30 | $11 |
| 2020-06-30 | $10 |
| 2020-03-31 | $10 |
| 2019-12-31 | $12 |
| 2019-09-30 | $12 |
| 2019-06-30 | $13 |
| 2019-03-31 | $13 |
| 2018-12-31 | $12 |
| 2018-09-30 | $11 |
| 2018-06-30 | $11 |
| 2018-03-31 | $10 |
| 2017-12-31 | $11 |
| 2017-09-30 | $9 |
| 2017-06-30 | $8 |
| 2017-03-31 | $8 |
| 2016-12-31 | $9 |
| 2016-09-30 | $8 |
| 2016-06-30 | $9 |
| 2016-03-31 | $8 |
| 2015-12-31 | $8 |
| 2015-09-30 | $8 |
| 2015-06-30 | $8 |
| 2015-03-31 | $8 |
| 2014-12-31 | $8 |
| 2014-09-30 | $7 |
| 2014-06-30 | $7 |
| 2014-03-31 | $6 |
| 2013-12-31 | $8 |
| 2013-09-30 | $7 |
| 2013-06-30 | $7 |
| 2013-03-31 | $6 |
| 2012-12-31 | $7 |
| 2012-09-30 | $7 |
| 2012-06-30 | $7 |
| 2012-03-31 | $7 |
| 2011-12-31 | $10 |
| 2011-09-30 | $9 |
| 2011-06-30 | $9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Laser Systems and Components | $0.017B | $0.053B |
| IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IPG Photonics (IPGP) | United States | $5.404B | 89.66 |
| Applied Energetics (AERG) | United States | $0.246B | 0.00 |